探索COPD中的分子机制和生物标志物:当前进展和前景的概述
Chin-Ling Li1, Shih-Feng Liu1,2,3
1Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
International journal of molecular sciences
|July 13, 2024
概括
分子研究促进了对慢性阻塞性肺病 (COPD) 的理解. 对COPD病原体,生物标志物和治疗方法的洞察力为个性化医疗和改善患者治疗结果铺平了道路.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题,其特点是逐渐限制空气流量和呼吸系统症状.
- 了解COPD的分子机制对于开发有效的治疗方法和管理疾病进展和恶化至关重要.
研究的目的:
- 审查COPD分子研究的最新进展.
- 探索COPD的基本分子途径,生物标志物,治疗点和新兴技术.
- 突出分子洞察力对个性化COPD医学的潜力.
主要方法:
- 关于COPD分子生物学现有文献的综述.
- 分析关键的分子通路,包括炎症,氧化应激和遗传/表观遗传因素.
- 检查用于COPD研究的omics技术 (基因组学,转录组学,蛋白质组学,代谢组学).
主要成果:
- 确定了COPD病变的关键分子驱动因素,包括炎症,氧化应激和蛋白酶-抗蛋白酶失衡.
- 突出了遗传和表观遗传因素在COPD易感性和疾病异质性中的作用.
- 证明了omics技术在识别新型COPD生物标志物和治疗点方面的实用性.
结论:
- 了解COPD的分子基础为开发量身定制的治疗策略提供了重大潜力.
- 将分子见解纳入临床实践可以提高COPD的诊断,治疗和管理.
- 个性化医疗方法有望改善患者的治疗结果,并减少COPD的全球负担.
相关概念视频
COPD: Pathogenesis and Clinical Features
257
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
257
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


